Furosemide + Sodium Zirconium Cyclosilicate Interaction
Unknowninteraction on record
Description
However, there was an increase in systemic exposure to weak acids such as furosemide and atorvastatin, and a decrease in systemic exposure to weak bases such as dabigatran when co-administered with LOKELMA, as shown in Figure 2.
Source: FDA drug label - sodium zirconium cyclosilicate